Clinical Trial Update: Pilot Study of Sleep Therapy and Biomarkers in Children With Autism Spectrum Disorders [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating sleep therapy and biomarkers in children with autism spectrum disorder. The trial was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Snippet

Sponsor: Stony Brook University | Conditions: Autism Spectrum Disorder | Phase 2 | Status: TERMINATED | Results posted: 2024-06-06